Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
Luca Cassetta, Kirsten Bruderek, Joanna Skrzeczyńska-Moncznik, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001223-e001223
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Circulating tumor cells: biology and clinical significance
Danfeng Lin, Lesang Shen, Meng Luo, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 606
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Kai Li, Houhui Shi, Benxia Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 511
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 351
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Sara Falck‐Jones, Sindhu Vangeti, Meng Yu, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 103
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 58
Neutrophils in cancer: dual roles through intercellular interactions
Xinyu Yu, Changhui Li, Zijin Wang, et al.
Oncogene (2024)
Closed Access | Times Cited: 22
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications
Daoqi Zhu, Siying Zeng, Chao Su, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 16
Monocyte Regulation in Homeostasis and Malignancy
Amy Robinson, Claudia Z. Han, Christopher K. Glass, et al.
Trends in Immunology (2021) Vol. 42, Iss. 2, pp. 104-119
Open Access | Times Cited: 99
Redefining macrophage and neutrophil biology in the metastatic cascade
Esra Güç, Jeffrey W. Pollard
Immunity (2021) Vol. 54, Iss. 5, pp. 885-902
Open Access | Times Cited: 98
Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms
Ganping Wang, Ming Zhang, Maosheng Cheng, et al.
Cancer Letters (2021) Vol. 507, pp. 55-69
Open Access | Times Cited: 74
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
Christophe Vanhaver, Pierre van der Bruggen, Annika M. Bruger
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2872-2872
Open Access | Times Cited: 59
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Shweta Joshi, Andrew B. Sharabi
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108114-108114
Open Access | Times Cited: 52
N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology
Benedict Boateng Antuamwine, Rebeka Bosnjakovic, Francisca Hofmann‐Vega, et al.
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 250-279
Open Access | Times Cited: 51
Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression
Yueli Xu, Jiaxian Yan, Ye Tao, et al.
Science (2022) Vol. 377, Iss. 6610, pp. 1085-1091
Closed Access | Times Cited: 49
A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs
Dylan T. Ammons, R. Adam Harris, Leone S. Hopkins, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
Shifen Wang, Xingyun Zhao, Siwen Wu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors
Francesca Pettinella, Barbara Mariotti, Chiara Lattanzi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101380-101380
Open Access | Times Cited: 10
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 9
State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers
Scott Strum, Mads Hald Andersen, Inge Marie Svane, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
Vera M. Kho, Vera E. Mekers, Paul N. Span, et al.
Cellular Immunology (2021) Vol. 362, pp. 104298-104298
Open Access | Times Cited: 51
Paeonol inhibits the progression of intracerebral haemorrhage by mediating the HOTAIR/UPF1/ACSL4 axis
Zhenglong Jin, Wen-Ying Gao, Shaojun Liao, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110106-175909142110106
Open Access | Times Cited: 50
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Adithya Gopinath, Phillip Mackie, Basil Hashimi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 32
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling
Feyza Gül Özbay Kurt, Beatrice-Ana Cicortas, Bianca M. Balzasch, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 9, pp. e009552-e009552
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top